Liaoning Chengda Biotechnology Co. Ltd. Class ASSE: 688739

"LIAONING CHENGDA BIOTECHNOLOGY CO., LTD."Announcement on Convening the 2026 Semi-annual Performance Briefing

Sep 15, 2026 · Issued by Liaoning Chengda Biotechnology Co. Ltd. Class A via Shanghai Stock Exchange

Announcement on Convening the 2026 Semi-annual Performance Briefing

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Liaoning Chengda Biotechnology Co. Ltd. Class A

"LIAONING CHENGDA BIOTECHNOLOGY CO., LTD."Special Report on the Deposit and Actual Use of Raised Funds for the First Half of 2026Aug 25
"LIAONING CHENGDA BIOTECHNOLOGY CO., LTD."Announcement on the Results of the Special Governance Review by the Audit Committee of the Board of DirectorsAug 21
"LIAONING CHENGDA BIOTECHNOLOGY CO., LTD."Announcement on the Initiation of Phase I Clinical Trial for Influenza Vaccine (Split Virion, High-Dose)Jul 18
"LIAONING CHENGDA BIOTECHNOLOGY CO., LTD."Announcement on Reply to Letter of Supervision and Inquiry on Information Disclosure of 2025 Annual ReportJul 11

All Liaoning Chengda Biotechnology Co. Ltd. Class A news releases